More Access and Evidence Articles
Access and Evidence
Market Access and what payers really want
Marcus Deans examines why market access depends on understanding the needs of
payers.
Access and Evidence
Market Access and value-based pricing
Marcus Deans explores the competitive advantages of value-based pricing
Access and Evidence
Health economics data and market access
Peter Mansell reports on how pharmacoeconomics can help define data
requirements to match market access plans.
Access and Evidence
Key factors for market access
Ed Schoonfeld of ZS Associates offers tips for market access success, from
scenario analysis to risk sharing.
Access and Evidence
Breaking into the Brazilian pharma market
To succeed in Brazil, find the right partner, the right product mix, and the
right pricing. Rajesh Chhabara reports.